Treatment of DCIS Needs to Consider Patient Age and Tumor

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 6 No 6
Volume 6
Issue 6

CHICAGO--Despite an overall trend toward breast conservation, many breast cancer authorities believe that ductal carcinoma in situ (DCIS) too often is treated by mastectomy, and that axillary dissection and irradiation frequently are performed unnecessarily.

CHICAGO--Despite an overall trend toward breast conservation, many breastcancer authorities believe that ductal carcinoma in situ (DCIS) too oftenis treated by mastectomy, and that axillary dissection and irradiationfrequently are performed unnecessarily.

In order to make the "punishment fit the crime," physicianstreating DCIS need to balance the extent of surgery and the applicationof irradiation with a number of factors, William Wood, MD, said at the50th Cancer Symposium of the Society for Surgical Oncology. These includenot only tumor size and margins, but also tumor grade and the patient'sage.

Since DCIS can develop into invasive disease, "we can't take ittoo lightly," said Dr. Wood, professor and chairman of the Departmentof Surgery, Emory University School of Medicine. However, he said, a formaltreatment algorithm for DCIS "requires thoughtful application basedupon the number of years a woman would be at risk, the likely biology ofthe tumor, and its extent."

The algorithm presented by Dr. Wood involves surgical excision of theDCIS with a relatively small resection margin for biopsy; magnificationview mammog-raphy to make sure there is no stream of DCIS moving towardthe nipple or areola or going off elsewhere in the breast; and detailedpathologic evaluation.

DCIS that has a 1- to 4-mm focus and 5- to 10-mm margin would be observedafter excision, according to this algorithm. "I would do nothing else;I think any additional treatment is likely to be overtreatment," Dr.Wood said.

For DCIS with a 5- to 20-mm focus and 5-mm to 10-mm margin, Dr. Woodwould add irradiation. Lumpectomy and radiation therapy would also be appropriatefor more than 20 mm of tumor as long as a 10-mm clear margin could be obtainedand the breast could be preserved in appearance.

The algorithm calls for more extensive treatment of a comedo or high-gradetumor, particularly in a young patient. Less extensive treatment wouldbe indicated "in an older patient where a low-grade disease mightnever become an event in her lifetime," he said.

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.